Short answer
Mirum Pharmaceuticals, Inc. (MIRM) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders re-elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors through 2029.
Mirum Pharmaceuticals, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders re-elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors through 2029
- Timothy Walbert received 32,329,718 votes for and 14,084,823 withheld, signaling comparatively weaker support
- Ernst & Young LLP ratified as independent auditor for fiscal 2026 with 49,993,514 votes for
- Executive compensation approved advisory vote, with 44,534,575 votes for and 1,866,719 against
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Mirum Pharmaceuticals, Inc. 8-K filings
Get the next MIRM 8-K as it lands
Follow MIRM for push alerts, or ask the research agent what this filing means.